The Next Generation Therapeutics Scientific Working Group (SWG) seeks to catalyze opportunities for team science within and across Emory CFAR institutions to set the foundation for future exploration and development of (i) novel approaches for viral suppression in PWH using combinations of therapeutics that overcome drug resistance associated with current ART and are delivered as formulations designed to facilitate their long-term release; and (ii) immune-based strategies, focusing on those FDA-approved for other diseases, aimed at targeting and limiting HIV residual disease and HIV reservoirs.

Key SWG Activities

Activities will include hosting research proposal feedback sessions, educational, networking events, and/or career development sessions as opportunities for CFAR Members, CDC staff, and Georgia Tech and Morehouse SOM faculty to interact; provide structured mentoring for Early-Stage Investigators in the field to ensure a robust scientific future; and promote multi-investigator applications to the CFAR Developmental Core and ultimately to the NIH.